By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



346A Lurgan Road

New Hope  Pennsylvania  18938  U.S.A.
Phone: 215-371-2874 Fax: n/a



Drug Discovery

Company News
Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration 1/9/2012 6:30:16 AM
Southern Research Institute Signs Agreement with BioLeap for Fragment-Based Drug Design Technology 12/13/2011 11:02:04 AM
BioLeap Technology Aids Drug Discovery, GlaxoSmithKline (GSK) and Unilever (UN) Amongst Early Adopters 8/24/2011 8:25:48 AM
BioLeap Moves Headquarters and Expands Staff to Meet Demand for Its Novel Molecular-Design Services 6/14/2011 7:44:28 AM
BioLeap Names Keith Mackay as Vice President for Sales in Next Step to Further Commercialize Novel Molecular Design 5/4/2011 10:30:35 AM
BioLeap Enters into Research Collaboration with Syngenta on Molecular Design of Crop Protection Products 4/5/2011 8:31:00 AM
BioLeap Announces the Addition of Dr. Gene Cordes to Its Board of Directors 5/3/2010 9:12:42 AM
BioLeap Secures $5M Series A Financing from Adams Capital Management and Quaker BioVentures, Inc. 1/12/2010 9:53:08 AM
BioLeap Wins GlaxoSmithKline (GSK) Contract to Design Novel Lead Compounds for Previously Intractable Targets for Important Unmet Medical Needs 9/8/2009 1:39:02 PM